Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 13, 2024. (Total: 232454Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Cerebral Infarction and CYP2C19[original query]
[Influence of CYP2C19 gene polymorphisms on the efficacy of clopidogrel treatment for the prevention of ischemic stroke following coronary stent implantation].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2017 Dec 34 (6): 839-843.
Li Guode, Chen Jingjuan, Xu Zuohang, Wang Yukai, Ding Nan, Peng Lingmei, Zhang Chengguo, Shao Y
[Correlation between CYP2C19 Gene Polymorphism and Elderly Cerebral Infarction].
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2018 Dec 40 (6): 765-768.
Fan Dan Jun, Li Chen Yi, Chen Jin, Ye Zi Qi
Whole blood dynamic platelet aggregation counting and 1-year clinical outcomes in patients with coronary heart diseases treated with clopidogrel.
Platelets 2020 9 32 (7): 968-974.
Wan Huaibin, Han Weichao, Wu Zhihao, Lie Zhenbang, Li Daqiang, Su Shaoh
Correlation study of CYP2C19 gene polymorphism and clopidogrel resistance in Han Chinese patients with cerebral infarction in Guizhou region.
Medicine 2021 2 100 (6): e24481.
Shi Guo-Xian, Zhao Zi-He, Yang Xiao-Yan, Lin Mu, Chen Zhou-X
Impact of Cilostazol Pharmacokinetics on the Development of Cardiovascular Side Effects in Patients with Cerebral Infarction.
Biological & pharmaceutical bulletin 2021 44 (11): 1767-1774.
Yokoyama Tasuku, Yamauchi Shigeru, Yamagata Keishi, Kaneshiro Yuta, Urano Yumiko, Murata Keiji, Maeda Toshio, Asahara Yoshinori, Kagawa Yoshiyu
The Dynamic Effect of Non-CYP3A4-Metabolized and CYP3A4-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction.
Frontiers in pharmacology 2021 10 12 738562.
Shi Hong Ting, Chen Yong Yuan, Li Xiao Ying, Luo Jian Hua, Zhong Guang Hong, Hu Jia Jia, Zhang Min, Zhou Bo Ro
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China.
Genetics research 2022 11 2022 1901256.
Chang Rong, Zhou Wenqin, Ye Yi, Zhang Xiaofei, Liu Yanmin, Wu Jinch
Differences in the Proportion of CYP2C19 Loss-of-Function Between Cerebral Infarction and Coronary Artery Disease Patients.
International journal of general medicine 2023 8 16 3473-3481.
Yuliang Shi, Yuxian Yang, Miaoling Feng, Weihan Ling, Tongguo Wei, Yumin Cao, Rui Zhong, Heming
Analysis of CYP2C19 gene polymorphism and influencing factors of pharmacological response of clopidogrel in patients with cerebral infarction in Zhejiang, China.
Frontiers in cardiovascular medicine 2023 2 10 1020593.
Mo Yijun, Lu Yao, Guo Fei, Wu Aihua, Weng Yueso
Exploring the impact of Cyp2C19 genetic polymorphism on the neurological and endothelial functions of acute cerebral infarction patients treated with dibenzyline.
Minerva medica 2024 7 .
Qingchuan Ma, Ni Mu, Xi Wu, Bing Yang, Na
[Clinical analysis of dual enhanced antiplatelet therapy after cerebrovascular intervention for reducing the risk of cerebral infarction recurrence].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2024 7 58 (7): 1062-1068.
Y Liu, Y Y Yin, Q L Lu, C Li, C Y Zha
TOP